Vancouver, BC -- (SBWire) -- 05/06/2021 --The global interventional cardiology devices market size is expected to reach USD 26.84 Billion at a steady CAGR of 8.7% in 2028, according to latest analysis by Emergen Research. Steady growth of the interventional cardiology devices market can be attributed to rising incidence of cardiovascular diseases. Cardiovascular disease is the most common cause of death in the US, and is responsible for around 655,000 deaths every year.
Among the regional markets, the interventional cardiology devices market in North America accounted for largest revenue share in 2020. This can be attributed to growing awareness about cardiovascular diseases, high deployment of advanced interventional cardiological treatments, and well-developed healthcare infrastructure in countries in the region. Additionally, robust presence of leading interventional cardiology device providers in the region is another key factor causative of steady market growth.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/570
Some Key Highlights in the Report
In June 2019, Terumo Corporation signed a partnership agreement with Orchestra BioMed, Inc. This partnership provides Terumo Corporation with exclusive rights for the development and marketing of Virtue Sirolimus-Eluting Balloon (SEB).
Angioplasty stents find application to restore blood flow occurring due to blockage and to reduce heart attack risk. Stents are considered beneficial in reducing damage caused to heart muscles in the event of a heart attack. Also, stents may instantly relieve or reduce symptoms comprising chest pain, fatigue, and shortness of breath.
Among the end-use segments, the hospitals segment accounted for largest revenue share in 2020, which can be attributed to robust presence of experienced healthcare professionals for installation of interventional cardiology devices and more advanced and developed healthcare infrastructure, along with high purchasing power for advanced and dedicated interventional cardiology devices in countries in the region. Additionally, hospitals account for adverse event minimization in patients during critical procedures, including stent installation and cardiac catheterization.
Key players in the market include Abbott Laboratories, Terumo Corporation, iVascular, Boston Scientific Corporation, Edwards Lifesciences Corporation, B.Braun Melsungen, Medtronic PLC, Koninklijke Philips NV, Biosensors International Group Ltd., and Endocor GmbH.
Market Segmentation:
The report categorizes the market into different key segments based on types and applications, along with key regional segmentation. The report offers insights into the segment expected to garner traction during the forecast period, and the region expected to dominate the market in the coming years.
Emergen Research has segmented the global interventional cardiology devices market on the basis of product type, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
Angioplasty Stents
Angioplasty Balloons
Catheters
Structural Heart Devices
Plaque Modification Devices
Guidewires
Hemodynamic Flow Alteration Devices
Others
End-Use Outlook (Revenue, USD Billion; 2018–2028)
Hospitals
Ambulatory Surgical Centers
Others
Key Geographies Encompassed in the Report:
North America (U.S., Canada)
Europe (U.K., Germany, Italy, France, Rest of EU)
AsiaPacific (India, Japan, China, Australia, Rest of APAC)
Latin America (Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request customization on the report @ https://www.emergenresearch.com/request-for-customization/570
Some Fundamental Market Parameters Elucidated in the Report:
Market dynamics: The Interventional Cardiology Devices market report explains the scope of various commercial possibilities over the next few years and further estimates revenue build-up over the forecast years. It analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers in developing vital strategies for profitable business expansion.
Competitive Outlook: The established market players operating in the Interventional Cardiology Devices industry have been listed in this report, with a major focus on their geographical reach and production facilities. To gain a competitive advantage over the other players in the Interventional Cardiology Devices industry, the leading players are focusing more on offering products at rational prices.
Objectives of the Report: The chief aim of the research report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Interventional Cardiology Devices market.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2020-2028
Chapter 3. Key Insights
Chapter 4. Interventional Cardiology Devices Market Segmentation & Impact Analysis
4.1. Interventional Cardiology Devices Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers' analysis
4.2.2.1. Rising incidence of cardiovascular diseases
4.2.2.2. Increasing prevalence of obesity
4.2.2.3. Advancement in technology
4.2.2.4. Growing demand for minimally invasive treatment
4.2.3. Market restraints analysis
4.2.3.1. Availability of substitutes
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter's Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Interventional Cardiology Devices Market By Product Type Insights & Trends, Revenue (USD Billion)
5.1. Product Type Dynamics & Market Share, 2021 & 2028
5.1.1. Angioplasty Stents
5.1.2. Angioplasty Balloons
5.1.3. Catheters
5.1.4. Structural Heart Devices
5.1.5. Plaque Modification Devices
5.1.6. Guidewires
5.1.7. Hemodynamic Flow Alteration Devices
5.1.8. Others
CONTINUED..!!
To read more about this report, visit @ https://www.emergenresearch.com/industry-report/interventional-cardiology-devices-market
Thank you for reading our report. For further information, please connect with us to know more about the customization feature. Our team will work towards providing you a report well suited to your requirements.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkdIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-interventional-cardiology-devices-market
Interventional Cardiology Devices Market Outlook, Industry Demand and Supply, Key Prospects, Pricing Strategies, Forecast and Top Manufacturers Analysis Report by Emergen Research
Rising incidence of cardiovascular diseases and increasing geriatric population are significant factor driving global interventional cardiology devices market growth.